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Curative effect of topical treatment of digital 
dermatitis with a gel containing activated 
copper and zinc chelate 
M. Holzhauer, C. J. Bartels, M. van Barneveld, C. Vulders, T. Lam
The efficacy of two topical treatments for painful ulcerative stage (M2) of bovine digital 
dermatitis (BDD) lesions was compared in a clinical trial conducted on five dairy farms in 2009 
to 2010. The first treatment was a water-based gel with active components copper and zinc 
(Intra Hoof-fit gel [IHF]) and the second treatment was a topical chlortetracycline spray (CTC 
spray). The experimental unit for this study was the hindleg with the presence of a BDD lesion. 
Cure was defined as the transition of an M2 lesion into a healed (M0) or a non-painful chronic 
stage (M4) of BDD at D28. On day 0, cows with M2 BDD lesions were photographed and were 
treated with either IHF or CTC. Subsequently, feet were photographed and scored on D28. 
The cure rate of M2 BDD lesions treated with IHF at D28 was 0.92 (CI 0.84 to 0.96) and was 
significantly better than for M2 BDD lesions treated with CTC, which was 0.58 (CI 0.47 to 0.68).
BOVINE digital dermatitis (BDD) was first described as a clinical con-
dition in 1974 (Cheli and Mortellaro 1974). It appears to have been 
a ‘true’ emerging disease as no reference had been made to the clini-
cal condition before. The disease is found in housed Holstein-Friesian 
dairy cows worldwide and is considered an important cause of infec-
tious lameness (Manske and others 2002b, Holzhauer and others 2006, 
Cramer and others 2008). BDD lesions typically develop on the plantar 
epidermis of the hindfeet. The ulcerative stage (M2), especially, tends to 
be very painful. Hence, BDD has been identified as a major welfare con-
cern (Cornelisse and others 1981, Blowey and Sharp 1988). In addition 
to the improvement of hygienic measurements, optimization of cubi-
cal sizes, prevention of overcrowding and regular preventive claw trim-
ming (Wells and others 1999) and rapid and effective treatment of infec-
tious stages, it is necessary to prevent transmission of BDD within a 
herd. The main causal factor of BDD is infection with Treponema species 
(Evans and others 2011). The most effective therapeutical treatments 
use antibiotics (Manske and others 2002a, Nishikawa and T aguchi 
2008, Berry and others 2010). Worldwide, there is a call for reduction 
of use of antibiotics in veterinary medicine (Phillips and others 2004). 
Although the quantities of antibiotics used in topical treatments of 
BDD are limited, an alternative would be welcome. The objective of 
this study was to evaluate the therapeutic effect of Intra Hoof-fit gel 
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(IHF; Intracare b.v.) on M2 BDD lesions, in comparison with chlortet-
racycline spray (CTC; Eurovet), based on the antibiotic CTC.
Material and methods
Participating herds and dairy cows
The trial was conducted on five commercial dairy farms in the north-
ern part of the Netherlands (see T able 1). All herds participated in 
biannual routine claw trimming programmes and started their par-
ticipation in the trial over time. Cows were selected based on regular 
visits by the claw trimmer. A next planned regular claw trimming 
was the starting day per herd. Selection criteria for participation of 
dairy farms were as follows: BDD prevalence >20 to 25 per cent, as 
assessed during regular previous claw trimming; herd size over 90 lac-
tating dairy cows; free stall with slatted floors and dairy cows of the 
Holstein-Friesian breed.
All lactating cows with M2 BDD lesions (M2) in their hindfeet at 
one of these regular claw trimming visits were included in the trial.
Study design and treatments
The trial was designed as a case-control study in which treatment 
with IHF was compared with treatment with CTC, which is an offi-
cially registered product, and this was treated as a positive control. A 
positive control was chosen for animal welfare reasons as not to deny 
animals treatment of the painful M2 stage of BDD. All BDD lesions 
were dry cleaned, macroscopically classified and recorded at D0 and 
Table 1: Information of the participating dairy herds in the clinical 
trial
Herd Start End
Number 
of cows
Number of hindlegs 
in the trial Floor
1 September 2009 October 2009 116 39 Slats
2 October 2009 December 2009 170 59 Slats with 
scraper
3 November 2009 December 2009 90 10 Slats
4 December 2009 January 2010 132 20 Slats
5 January 2010 March 2010 183 54 Slats with 
scraper
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300 hindlegs calculated to be 
necessary for each group. The 
study was stopped after execut-
ing the trial in five herds where 
49, 64, 13, 20 and 59 hindfeet 
were treated. The comparison 
of the IHF and CTC group made 
for parity, days in milk and milk 
yield were not statistically different (p values were, respectively, 0.48, 
0.18 and 0.27).
In 18 dairy cows (23 hindfeet, nine IHF and 14 CTC), the pro-
tocol could not be fully executed, for different reasons. The most 
dominant reason was an extra treatment with CTC, due to a painful 
lesion (eight hindfeet, all belonging to the CTC group). This repre-
sented 8 per cent of the cows treated with CTC. For medical reasons, 
five cows (3x mastitis, 1x fractured leg and 1x serious sole ulcer) were 
culled by the farmers. Results of six hindfeet had to be excluded, due 
to scoring and/or administrative mistakes. The M2 BDD cure rates 
of IHF and CTC are presented in T ables 2 and 3. The cure rate of M2 
BDD lesions treated with IHF was 0.92 (86/94, CI 0.84 to 0.96) and 
with CTC 0.58 (51/88, CI 0.47 to 0.68), indicating a risk ratio (RR) 
of 1.58 (95 per cent CI 1.31 to 1.91). The RR per herd was more 
than unity for IHF over CTC (four out of five herds) and differed 
statistically significant in three out of five herds (see T ables 2 and 3). 
In herd 4, the cure rate for IHF was 0.90 and for CTC 1.00. On D7, 
all M2 (from Day 0) had become non-M2 for IHF compared with 
32 remained M2 for CTC (p <0.01). On day 21, 21 per cent were 
M0 for IHF compared with 2 per cent for CTC and on D28, 51 per 
cent have become M0 for IHF compared with 10 per cent for CTC 
(p <0.01).
Discussion
Individual topical treatment with antibiotics is the most common-
ly reported method to treat BDD (Laven and Logue 2007). This is 
widely accepted as the treatment of choice because it is generally 
accepted as effective and there is a lack of scientific information on 
the efficacy of non-antibiotic preparations. T opical treatment has the 
advantage of limited antibiotic usage and it also fulfils the require-
ments of legislation. However, alternatives for all antibiotic treat-
ments are desirable, because of reasons of possible development of 
antibiotic resistance and environmental pollution (T acconelli 2010). 
In the UK, Pastell and others (2010) found no relationship between 
lameness and the presence of BDD. In that study, however, BDD 
was not classified based on the stage of infection. Laven and Hunt 
(2002) evaluated the effect of two topical antibiotic sprays (with 
valnemulin and lincomycin) in the treatment of BDD. At D14, a 
significant reduction in lesion score for both treatment groups was 
found with cure rates of 28 and 40 per cent. Laven (2006) studied 
the efficacy of two antibiotics, cefquinome applied parenterally for 
three days and for five days and erythromycin applied parenterally 
by injection once. He also compared the results with erythromycin 
in a walk-through footbath. Only M2 BDD lesions were included 
in that study. The results of all treatments were comparable with 
the erythromycin footbath application; only the five-day applica-
tion of cefquinome had a significantly better result. Unfortunately, 
the best strategy (five days application) is not only expensive, but 
also has a higher risk of development of resistance against modern 
antibiotics, by the increased use of a third-generation cephalosporine. 
Therefore, this strategy is less desirable. Recently, Potter and Burnell 
(2010) compared the curative effect of a copper/zinc and aloe vera 
gel as treatment of M2 BDD lesions, with an antibiotic powder 
(tylosin tatrate) on 41 foots. At D7, a lesion surface area reduction 
of 74 per cent was found after treatment with the gel while the 
antibiotic treatment gave a 48 per cent reduction. The copper/zinc 
gel used in that study is comparable with the gel used in our study 
and the results are in line with this study. In the USA, Britt and 
others (1996) studied the efficacy of three topical sprays (oxytetracy-
cline, acidified ionised copper solution and acidified sodium chlorite 
solution) on lameness three weeks after treatment. Mean lameness 
score decreased (that is, cows were less lame) for all three treatment 
groups but increased for the control group. Berry and others (1999) 
D28. Classification of BDD was performed according to a standard-
ised scoring system comprising five stages (M0 to M4) as developed 
by Döpfer and others (1997). According to this scoring system, M0 is 
recorded for feet with normal digital skin where BDD is absent during 
macroscopic inspection; M1 is the early-stage lesion (0 to 2 cm) that 
is not painful; M2 is the classical ulcerative stage with a diameter >2 
cm that is often painful upon touch; M3 is the healing stage when 
the lesion is covered by a scab and M4 is the chronic stage character-
ised by dyskeratosis or proliferation of the surface that is generally not 
painful. M2 is the most infectious stage (Mumba and others 1999). If 
different stages of BDD were present, the leg was typed according to 
the most prominent stage of the lesion. Besides scoring of the lesions, 
attention was paid to the presence of adverse or side effects with spe-
cific attention for redness and swelling of the treated skin. On D0, the 
first M2 lesion found in a herd was assigned as treatment group A or 
B by flipping a coin. Subsequent lesions were alternately assigned to 
group A or B.
In group A, 5 g of IHF was applied with a brush. The lesion was 
then covered with cotton wool and held in place by an elastic band-
age (CoRip Flexible Cohesive Bandage GB 11). On D3 and D7, again 
approximately 5 g of IHF was applied by use of a brush, but with-
out a bandage (see time frame, Fig 1). In group B, CTC was applied 
by spraying twice for three seconds from 15 to 20 cm distance with 
30 seconds in-between treatments. This treatment was, accordingly 
the prescription of the producers,repeated at days 1 and 2. All scores, 
recordings and treatments were performed in a trimming chute by 
the same veterinarian (MvB). All hindlegs with M2 lesions were 
photographed at D0 and D28 for objective evaluation afterwards. No 
walk-through footbaths or other treatments were applied in the last 
three weeks before the start of and during the trial period. For reasons 
of practical feasibility, performance in regular herds and for financial 
reasons, no further histopathological investigation of the lesions was 
performed. Daily evaluations were performed by the dairy farmer for 
the presence of painful lesions. In case of necessary extra treatments, 
these were always executed with CTC (the registered product). These 
lesions were not followed up any further and were considered not to 
be cured. Cows that were treated for other reasons during the trial (eg, 
mastitis) were excluded.
Statistical analysis
The experimental unit was a hindleg with an M2 BDD lesion. Cure 
was defined as the transition of M2 BDD into a healed (M0) or non-
painful chronic stage (M4) at D28. The sample size was calculated 
to detect a 10 per cent difference between the cure rate of CTC (80 
per cent, Holzhauer and others 2008) and IHF (70 per cent; Moore 
and others 2001) with 95 per cent confidence and 80 per cent power. 
Based on these assumptions, a sample size of 300 hindlegs with M2 
lesions in each group was needed. A Kruskal-Wallis test was used for 
comparison of the different treatment groups for parity, days in milk 
and milk yield, where the results might be influenced by these criteria 
(Holzhauer and others 2006).
A two-sample, two-sided proportion test was used to compare the 
cure rate of IHF with CTC. Data were analysed in STATA/SE 10.0 
comparing the proportions of cured M2 lesions, 28 days after the ini-
tial treatment, in cows treated with IHF or CTC. Finally, a Fisher exact 
test was used to evaluate the transitions from M2 to M0 at D7 for the 
different treatment groups and a proportion test was used to evaluate 
the transitions from M2 to M0 at D21 and D28 for the different treat-
ment groups (p-value <0.05).
Results
In total, 205 hindfeet (divided over 172 cows) were treated, 103 with 
IHF and 102 with CTC. Because the outcomes of the comparison 
differed considerably from the assumptions, these were less than the 
FIG 1: Time frame for scorings and treatments of the different products according to protocol
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B
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evaluated the efficacy of a Serpens species bacterin vaccine combined 
with topical administration of lincomycin HCl for the treatment 
of the M2 BDD in 30 cows. All cows in that study were examined 
on D30 and D110 and a cure rate of approximately 60 per cent was 
found in both groups. Shearer and Hernandez (2000) compared the 
efficacy of a topical treatment with oxytetracycline solution with 
the efficacy of a product containing reduced soluble copper and a 
peroxide compound with increased levels of cationic agent, among 
78 dairy cows with M2 BDD. Based on the lesion scores at D28, the 
copper product appeared most effective for the treatment of BDD. 
The too low efficacy of the oxytetracycline solution (only 20 per 
cent cure at D28) was hypothesised by them to be an indication of 
possible antibiotic resistance. Moore and others (2001) studied the 
efficacy of treating M2 BBD with a non-antimicrobial cream (solu-
ble copper with peroxide and a cationic agent) in comparison with 
a lincomycin HCl paste and a negative control group in 98 cows. At 
D28, the percentage of healed lesions for the different therapies was 
45.5, 64.5 and 21.9 per cent and the RR of cure compared with no 
treatment was 2.08 and 2.95. In a recent study in the USA (Berry 
and others 2010), the efficacy of lincomycin and oxytetracycline 
for topical treatment of BDD was examined via gross visual exami-
nation, histological evaluation and bacteriologic evaluation in 25 
dairy cows with ulcerative BDD. No difference between responses 
to lincomycin and oxytetracycline were found (73 and 68 per cent, 
respectively).
In most studies on topical antibiotic treatments, cure rates at D30 
around 60 to 70 per cent are found, except in the study of Shearer 
and Hernandez (2000). Data in the present study indicated that the 
curative effect of IHF at D28 after the start of treatment was 92 per 
cent, which is better than antibiotic treatment in other studies (T able 2). 
T able 3 gives a more detailed insight and it shows that (for IHF) at D7 
all lesions were cured (≠M2), but at a later stage some M2 lesions 
re-occur, where it is not clear if it is reinfection or reoccurrence of a 
non-healed lesion. The curative effect of topical application of CTC 
in the present study was in line with cure rates of antibiotics applied 
topically on BDD lesions in other studies. Thus, the application of 
IHF seems to be a good alternative for antibiotic treatment of M2 
BDD lesions. Although copper and zinc are considered to be toxic 
for the environment, copper/zinc pollution seems to be limited due to 
a limited number of individual cows per herd and the amount of gel 
applied (<5 g) and is expected to have a very limited influence on the 
environment.
TABLE 2: Estimation of the overall cure at D28 of M2 BDD lesions treated for the different 
herds and overall
Number CTC 
treated
CTC M2 
cured*
Cure rate 
CTC
IHF 
treated
IHF M2 
cured
Cure rate 
IHF
Cure rate 
difference
p-Value 
(Fisher exact test)
Herd 1 16 7 0.44 23 23 1.00 2.7 0.01
Herd 2 30 18 0.60 29 25 0.86 1.4 0.04
Herd 3 4 3 0.75 6 6 1.00 1.3 0.4
Herd 4 10 10 1.00 10 9 0.90 0.9 1.00
Herd 5 28 13 0.46 26 23 0.88 1.9 <0.01
Total 88 51 0.58 94 86 0.92 1.6 <0.01
*All transitions from painful M2 lesions to M0, 1, 3 and 4
CTC Chlortetracycline spray, IHF Intra Hoof-fit gel
TABLE 3: Scoring of DD lesions on D7, D21 and D28 after treatment 
of M2 BDD with IHF and CTC spray
M0 M1 M2 M3 M4
Day 7 IHF 0 30 0 67 0
CTC 0 10 32 56 0
Day 21 IHF 20 54 2 17 1
CTC 2 45 37 11 1
Day 28 IHF 48 32 8 2 4
CTC 9 37 37 1 4
CTC Chlortetracycline spray, IHF Intra Hoof-fit gel, M0 Healed stage, M1 Early-stage 
lesion,
M2 Ulcerative stage, M3 Healing stage, M4 Chronic stage
In conclusion, the use of topical IHF gel 
under a bandage at D0 and additional appli-
cation at D4 and D7 (without bandage) 
were effective for the treatment of the M2 
stage of BDD and were significantly better 
than three consecutive days of topical treat-
ment with CTC.
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